๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

BASF works on new gas-to-olefin process

Publisher
Elsevier Science
Year
2008
Weight
57 KB
Volume
2008
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis

150 M in the two projects since 2006. According to Shell Malaysia Gas & Power, the Bintulu plant will be developed as an R&D centre for GTL technology for the group. The two projects are an enhanced Shell gasification process for GTL to increase the efficiency of the process through optimised energy integration and the heavy paraffin synthesis demonstration project, a pilot scale facility that could help enhance the performance of Shell's proprietary GTL catalyst through more efficient and effective conversion of feed gas. The investment at Bintulu will be mainly to expand product range and maintenance and upgrading works rather than building capacity. The plant has a production capacity of 14,700 bbl/day of liquid products and waxes and employs about 360 persons.

๐Ÿ“œ SIMILAR VOLUMES

BASF advances dehydro technologies; halt
BASF advances dehydro technologies; halts work on syngas-to-olefins process
๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science โš– 62 KB

volumes 16%, prices 23%, portfolio 0%, currencies 2%). Although the group increased sales of refinery catalysts, sales volumes of chemical and automotive catalysts were significantly lower than in 2008. A higher volume of business in emerging markets, particularly in Asia Pacific, could not offset t

BASF advances novel syngas-to-olefins pr
BASF advances novel syngas-to-olefins process
๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science โš– 57 KB

150 M in the two projects since 2006. According to Shell Malaysia Gas & Power, the Bintulu plant will be developed as an R&D centre for GTL technology for the group. The two projects are an enhanced Shell gasification process for GTL to increase the efficiency of the process through optimised energy

BASF to commercialise new THF process
BASF to commercialise new THF process
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science โš– 37 KB

The outlook for 2002 is also included. Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical areas.